Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by spesestsemperon Apr 18, 2024 4:50pm
234 Views
Post# 35996800

New shareholder

New shareholderHi everyone

Im a recently new shareholder . I decided to invest in this company after looking at all the variables . In my research , ive discovered a lot of false starts and disgruntled shareholders . In life , nothing goes as one expects . I'm hoping that they finally are a bit more focused . I'm not particular on researchers runnning a company . They like to research , lose focus . My expectations are a bit less than most here . I see it going to 5-6 dollars . I'm fine with that as from the current shar price , thats a good win . I think they have something obviously but just dont see anyone stepping up with a muti billion buyout . 500 million range i can see . I'd be happy with that . Im wondering if the recent federal budget will move things up . For our american friends , they introduced an increase in the capital gains tax from half to two thirds . It comes into effect june 25th . Just some random thoughts - heres hoping for the best . 

<< Previous
Bullboard Posts
Next >>